Servicio de Reumatología, Hospital Universitario Virgen de las Nieves, Facultad de Medicina, Universidad de Granada, España.
Unidad de Investigación, Sociedad Española de Reumatología, Madrid, España.
Reumatol Clin (Engl Ed). 2020 Mar-Apr;16(2 Pt 2):133-148. doi: 10.1016/j.reuma.2018.11.004. Epub 2019 Jan 25.
The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS.
A panel of 4rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for the document elaboration, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network, SIGN levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques).
Forty-six recommendations were drawn up, addressing 5main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the last 25, referring to the areas of: obstetric APS and special situations. The document provides a table of recommendations and treatment algorithms.
Update of SER recommendations on APS is presented. This document corresponds to part II, related to obstetric SAF and special situations. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A part I has also been prepared, which addresses aspects related to diagnosis, evaluation and treatment.
抗磷脂综合征(APS)的诊断难度和临床表现谱决定了治疗选择,这促进了西班牙风湿病学会(SER)基于最佳证据制定建议。这些建议可以为参与 APS 管理的风湿病学家和其他专家提供参考。
成立了一个由 4 名风湿病学家、1 名妇科医生和 1 名擅长 APS 的血液学家组成的专家组,他们是通过 SER 的公开招募或基于专业功绩预先选定的。工作阶段包括:确定文件编写的关键领域、对科学证据进行分析和综合(使用苏格兰校际指南网络,SIGN 证据水平),并根据这些证据和正式评估或合理判断技术(共识技术)制定建议。
制定了 46 条建议,涵盖 5 个主要领域:诊断和评估、初级血栓预防的测量、APS 或二级血栓预防的治疗、产科 APS 的治疗和特殊情况。这些建议还包括新型口服抗凝剂的作用、这些主题中确定的复发问题或关键风险因素。本文档反映了过去 25 年的情况,涉及产科 APS 和特殊情况。本文档提供了一份建议和治疗算法表。
提出了更新的 SER 关于 APS 的建议。本文档对应第二部分,涉及产科 APS 和特殊情况。这些建议被认为是临床医生决策的工具,既要考虑到有经验的 APS 医生的决策,也要考虑到患者的情况。还编写了第一部分,涉及诊断、评估和治疗相关的方面。